LOS ANGELES (Sept. 30, 2014) – The ALS Program at Cedars-Sinai has become the first in Southern California to be named an ALS Association Certified Treatment Center of Excellence – a distinction that ...
NEW YORK, NY—A new initiative, Silence ALS, will develop experimental personalized therapies to treat patients with rare genetic forms of ALS (also known as Lou Gehrig’s disease). The initiative ...
SEATTLE, Dec. 10, 2019 /PRNewswire/ -- The Answer ALS research program, a consortium of medical research centers, technology companies like Avanade, and 1,000 ALS patients, has completed phase one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results